INHIBITION OF RESTENOSIS THROUGH ANTISENSE

10 July 1994

- Researchers at Osaka University, Japan, have reportedly succeeded in completely inhibiting restenosis for eight weeks in rats following balloon injury using two antisense oligonucleotides, PCNA and cdc2 kinase, and a liposome containing the protein HGM-1, which incorporates the two factors into the cell nucleus. When the liposome was introduced into the vascular smooth muscle cells of the carotid artery of rats, it was reported that growth of the cells could be completely inhibited for eight weeks.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight